Tissue engineered human skin equivalents

Pharmaceutics

Volumn 4, Issue 1, 2012, Pages 26-41

  Zhang, Zheng ^b   Michniak Kohn, Bozena B ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Human skin equivalents; Regenerative medicine; Skin grafts; Skin models; Tissue engineering

Indexed keywords

TISSUE SCAFFOLD;

ANIMAL TESTING ALTERNATIVE; BIOCHEMISTRY; BIOLOGICAL MODEL; BURN; CORROSION; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; FULL THICKNESS SKIN GRAFT; HUMAN; HUMAN SKIN EQUIVALENT; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; SKIN GRAFT; SKIN INJURY; SKIN IRRITATION; SKIN PERMEABILITY; SKIN TRANSPLANTATION; TISSUE ENGINEERING; TOXICITY TESTING;

EID: 84863350083     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics4010026     Document Type: Review

References (69)

1. Holbrook, K.A.; Wolff, K. The Structure and Development of Skin. In Dermatology in General Medicine, 6th ed.; Fitzpatrick, T.B., Eisen, A.Z., Wolff, K., Freedberg, I.M., Austen, K.F., Eds.; McGraw-Hill: New York, NY, USA, 1993.
2. Scheuplein, R.J.; Blank, I.H. Permeability of the skin. Physiol. Rev. 1971, 51, 702-747.
3. Briggaman, R.A.; Wheeler, C.E. The epidermal-dermal junction. J. Invest. Dermatol. 1975, 65, 71-84.
4. Parenteau, N.L.; Hardin-Young, J.; Ross, R.N. Skin. In Principles of Tissue Engineering, 2nd ed.; Lanza, R.P., Langer, R., Vacanti, J.P., Eds.; Academic Press: San Diego, CA, USA, 2000; pp. 879-890.
5. Hadgraft, J.; Guy, R.H. Feasibility Assessment in Topical and Transdermal Delivery: Mathematical Models and in Vitro Studies. In Transdermal Drug Delivery, 2nd ed.; Guy, R.H., Hadgraft, J., Eds.; Marcel Dekker, Inc.: New York, NY, USA, 2003; Chapter 1.
6. Zhang, Q.; Grice, J.E.; Li, P.; Jepps, O.G.; Wang, G.-J.; Roberts, M.S. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm. Res. 2009, 26, 1974-1985.
7. Vacanti, J.P.; Vacanti, C.A. The History and Scope of Tissue Engineering. In Principles of Tissue Engineering, 2nd ed.; Lanza, R.P., Langer, R., Vacanti, J.P., Eds.; Academic Press: San Diego, CA, USA, 2000; pp. 3-7.
8. Langer, R.; Vacanti, J.P. Tissue engineering. Science 1993, 260, 920-926.
9. Rheinwald, J.G.; Green, H. Serial cultivation of strains of human epidermal keratinocytes: The Formation of keratinizing colonies from single cells. Cell 1975, 6, 331-337.
10. Rheinwald, J.G.; Green, H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 1977, 264, 421-424.
11. Green, H.; Kehinde, O.; Thomas, J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl. Acad. Sci. USA 1979, 76, 5665-5668.
12. Bell, E.; Ehrlich, H.P.; Buttle, D.J.; Nakatsuji, T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981, 211, 1052-1054.
13. Deuel, T.F.; Kawahara, R.S.; Mustoe, T.A.; Pierce, A.F. Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Annu. Rev. Med. 1991, 42, 567-584.
14. Freed, L.E.; Hollander, A.P.; Martin, I.; Barry, J.R.; Langer, R.; Vunjak-Novakovic, G. Chondrogenesis in a cell-polymer-bioreactor system. Exp. Cell Res. 1998, 240, 58-65.
15. Freed, L.E.; Vunjak-Novakovic, G. Tissue Engineering Bioreactors. In Principles of Tissue Engineering, 2nd ed.; Lanza, R.P., Langer, R., Vacanti, J.P., Eds.; Academic Press: San Diego, CA, USA, 2000; Chapter 13, pp. 143-156.
16. Peppas, N.A.; Langer, R. New challenges in biomaterials. Science 1994, 263, 1715-1720.
17. Kohn, J.; Langer, R. Polymerization reactions involving the side chains of α-l-amino acids. J. Am. Chem. Soc. 1987, 109, 817-820.
18. Pachence, J.M.; Kohn, J. Biodegradable Polymers. In Principles of Tissue Engineering, 2nd ed.; Lanza, R.P., Langer, R., Vacanti, J.P., Eds.; Academic Press: San Diego, CA, USA, 2000; pp. 263-277.
19. Lee, K.Y.; Mooney, D.J. Hydrogels for tissue engineering. Chem. Rev. 2001, 101, 1869-1879.
20. Drury, J.L.; Mooney, D.J. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003, 24, 4337-4351.
21. Peppas, N.A.; Carr, D.A. Impact of absorption and transport on intelligent therapeutics and nano-scale delivery of protein therapeutic agents. Chem. Eng. Sci. 2009, 64, 4553-4565.
22. Baptista, P.M.; Orlando, G.; Mirmalek-Sani, S.H.; Siddiqui, M.; Atala, A.; Soker, S. Whole Organ Decellularization- a Tool for Bioscaffold Fabrication and Organ Bioengineering. In Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC'09), Minneapolis, MN, USA, 3-6 September 2009; pp. 6526-6529.
23. Atala, A.; Bauer, S.B.; Soker, S.; Yoo, J.J.; Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367, 1241-1246.
24. Tissue Engineering and Cell Transplantation: US Markets for Skin Replacements and Substitutes; Report #A426; Medtech Insight: Bridgeport, PA, USA, August 2010.
25. Guidance Document for the Conduct of Skin Absorption Studies. In OECD Environmental Health and Safety Publications, Series on Testing and Assessment, No. 28; Organisation for Economic Co-Operation and Development: Paris, France, 2004.
26. Panchagnula, R.; Stemmer, K.; Ritschel, W.A. Animal models for transdermal drug delivery. Methods Find. Exp. Clin. Pharmacol. 1997, 19, 335-341.
27. Kiowski, G.; Biedermann, T.; Widmer, D.S.; Civenni, G.; Burger, C.; Dummer, R.; Sommer, L.; Reichmann, E. Engineering melanoma progression in a humanized environment in vivo. J. Invest. Dermatol. 2011, 132, 144-153.
28. Commandeur, S.; Ho, S.H.; de Gruijl, F.R.; Willemze, R.; Tensen, C.P.; EI-Ghalbzouri, A. Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma. Exp. Dermatol. 2011, 20, 737-742.
29. Tjabringa, G.; Bergers, M.; van Rens, D.; de Boer, R.; Lamme E.; Schalkwijk, J. Development and validation of human psoriatic skin equivalents. Am. J. Pathol. 2008, 173, 815-823.
30. MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 2007, 445, 874-880.
31. Groen, D.; Poole, D.S.; Gooris, G.S.; Bouwstra, J.A. Is an orthorhombic lateral packing and a proper lamellar organization important for the skin barrier function? Biochim. Biophys. Acta 2011, 1808, 1529-1537.
32. Nowak, J.A.; Fuchs, E. Isolation and culture of epithelial stem cells. Methods Mol. Biol. 2009, 482, 215-232.
33. Midwood, K.S.; Williams, L.V.; Schwarzbauer, J.E. Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 2004, 36, 1031-1037.
34. Herndon, D.N.; Barrow, R.E.; Rutan, R.L.; Rutan, T.C.; Desai, M.H.; Abston, S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann. Surg. 1989, 209, 547-553.
35. Gallico, G.G.; O'Connor, N.E. Engineering a skin replacement. Tissue Eng. 1995, 1, 231-240.
36. Groeber, F.; Holeiter, M.; Hampel, M.; Hinderer, S.; Schenke-Layland, K. Skin tissue engineering- in vivo and in vitro applications. Adv. Drug Deliv. Rev. 2011, 63, 352-366.
37. O'Conner, N.E.; Mulliken, J.B.; Banks-Schlegel, S.; Kehinde, O.; Green, H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981, 317, 75-78.
38. Purdue, G.F. Dermagraft-TC pivotal efficacy and safety study. J. Burn Care Rehabil. 1997, 18, S13-S14.
39. Gentzkow, G.D.; Iwasaki, S.D.; Hershon, K.S.; Mengel, M.; Prendergast, J.J.; Ricotta, J.J.; Steed, D.P.; Lipkin, S. Use of dermagraft: A cultured human dermis to treat diabetic foot ulcers. Diabetes Care 1996, 19, 350-354.
40. Cuono, C.; Langdon, R.; McGuire, J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986, 327, 1123-1124.
41. Heimbach, D.; Luterman, A.; Burke, J.; Cram, A.; Herndon, D.; Hunt, J.; Jordan, M.; McManus, W.; Solem, L.; Warden, G.; Zawacki, B. Artificial dermis for major burns: A multi-center randomized clinical trial. Ann. Surg. 1988, 208, 313-320.
42. Shevchenko, R.V.; James, S.L.; James, S.E. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J. R. Soc. Interface 2010, 7, 229-258.
43. Maruguchi, T.; Maruguchi, Y.; Suzuki, S.; Matsuda, K.; Toda, K.; Isshiki, N. A new skin equivalent: Keratinocytes proliferated and differentiated on collagen sponge containing fibroblasts. Plast. Reconstr. Surg. 1994, 93, 537-544.
44. Eaglstein, W.H.; Iriondo, M.; Laszlo, K. A composite skin substitute (graftskin) for surgical wounds: A clinical experience. Dermatol. Surg. 1995, 21, 839-843
45. Sabolinski, M.L.; Alvarez, O.; Auletta, M.; Mulder, G.; Parenteau, N.L. Cultured skin as a "smart material" for healing wounds: Experience in venous ulcers. Biomaterials 1996, 17, 311-320.
46. Bello, Y.M.; Falabella, A.F. The role of graftskin (apligraf) in difficult-to-heal venous leg ulcers. J. Wound Care 2002, 11, 182-183.
47. Boyce, S.T.; Kagen, R.J.; Greenhalgh, D.G.; Warner, P.; Yakuboff, K.P.; Palmieri, T.; Warden, G.D. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J. Trauma 2006, 60, 821-829.
48. Ponec, M. Skin constructs for replacement of skin tissues for in vitro testing. Adv. Drug Deliv. Rev. 2002, 54, S19-S30.
49. Johsnon, E.W.; Meunier, S.F.; Roy, C.J.; Parenteau, N.L. Serial cultivation of normal human keratinocytes: A defined system for studying the regulation of growth and differentiation. In Vitro Cell. Dev. Biol. 1992, 28, 429-435.
50. Boehnke, K.; Mirancea, N.; Pavesio, A.; Fusenig, N.E.; Boukamp, P.; Stark, H.J. Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. Eur. J. Cell Biol. 2007, 86, 731-746.
51. Xie, Y.; Rizzi, S.C.; Dawson, R.; Lynam, E.; Richards, S.; Leavesley, D.I.; Upton, Z. Development of a three-dimensional human skin equivalent wound model for investigating novel wound healing therapies. Tissue Eng. Part C Method 2010, 16, 1111-1123.
52. Oliver, G.J.; Pemberton, M.A.; Rhodes, C. An in vitro model for identifying skin-corrosive chemicals. 1. Initial validation. Toxicol. in Vitro 1988, 2, 7-17.
53. Lelievre, D.; Justine, P.; Christiaens, F.; Bonaventure, N.; Coutet, J.; Marrot, L.; Cotovio, J. The Episkin Phototoxicity Assay (EPA): Development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. in Vitro 2007, 21, 977-995.
54. Gabbanini, S.; Lucchi, E.; Carli, M.; Berlini, E.; Minghetti, A.; Valgimigli, L. In vitro evaluation of the permeation through reconstructed human epidermis of essential oils from cosmetic formulations. J. Pharm. Biomed. Anal. 2009, 50, 370-376.
55. de Jager, M.; Groenink, W.; van der Spek, J.; Janmaat, C.; Gooris, G.; Ponec, M.; Bouwstra, J. Preparation and characterization of a stratum corneum substitute for in vitro precutaneuous penetration studies. Biochim. Biophys. Acta 2006, 1758, 636-644.
56. Wertz, P.W. Epidermal lipids. Semin. Dermatol. 1992, 11, 106-113.
57. Vicanova, J.; Boelsma, E.; Mommaas, A.M.; Kempenaar, J.A.; Forslind, B.; Pallon, J.; Egelrud, T.; Koerten, H.K.; Ponec, M. Normalization of epidermal calcium distribution profile in reconstructed human epidermis is related to improvement of terminal differentiation and stratum corneum barrier formation. J. Invest. Dermatol. 1998, 111, 97-106.
58. US and International Acceptance of Alternative Methods, 1998-2011 Chronological List, published by NICEATM-ICCVAM. Available online: http://iccvam.niehs.nih.gov/about/accept.htm (accessed on 23 December 2011).
59. The Regulatory Acceptance for Skin Corrosion and Skin Irritation can be found at the Method Validation website of ECVAM. Available online: http://ecvam.jrc.it/ (accessed on 23 December 2011).
60. Stark, H.J.; Boehnke, K.; Mirancea, N.; Willhauck, M.J.; Pavesio, A.; Fuesnig, N.E.; Boukamp, P. Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J. Investig. Dermatol. Symp. Proc. 2006, 11, 93-105.
61. EI-Ghalbzouri, A.; Lamme, E.N.; van Blitterswijk, C.; Koopman, J.; Ponec, M. The use of PEGT/PBT as a dermal scaffold for skin tissue engineering. Biomaterials 2004, 25, 2987-2996.
62. Thakoersing, V.S.; Ponec, M.; Bouwstra, J.A. Generating of human skin equivalents under submerged conditions- mimicking the in utero environment. Tissue Eng. Part A 2010, 16, 1433-1441.
63. Ponec, M.; Weerheim, A.; Kempenaar, J.; Mulder, A.; Gooris, G.S.; Bouwstra, J.; Mommaas, A.M. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J. Invest. Dermatol. 1997, 109, 348-355.
64. Thakoersing, V.S.; Gooris, G.S.; Mulder, A.; Rietveld, M.; EI-Ghalbzouri, A.; Bouwstra, J.A. Unraveling barrier properties of three different in-house human skin equivalents. Tissue Eng. Part C 2012, 18, 1-11.
65. Andreadis, S.T.; Hamoen, K.E.; Yarmush, M.L.; Morgan, J.R. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 2001, 15, 898-906.
66. Schmook, F.P.; Meingassner, J.G.; Billich, A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 2001, 215, 51-56.
67. Roy, S.D.; Fujiki, J.; Fleitman, J.S. Permeabilities of alkyl p-amino-benzoates through living skin equivalent and cadaver skin. J. Pharm. Sci. 1993, 82, 1266-1268.
68. Batheja, P.; Song, Y.; Wertz, P.; Michniak-Kohn, B. Effects of growth conditions on the barrier properties of a human skin equivalent. Pharm. Res. 2009, 26, 1689-1700.
69. Wilkins, L.M.; Watson, S.R.; Prosky, S.J.; Meunier, S.F.; Parenteau, N.L. Development of a bilayered living skin construct for clinical applications. Biotechnol. Bioeng. 1994, 43, 747-756.